On October 27th, the biannual 2019 Scientific Symposium on Cancer Research and Global Collaboration brought together the brightest minds of the National Foundation for Cancer Research (NFCR) and the Asian Foundation for Cancer Research (AFCR). Held in Rockville, MD, the three-day gathering was a chance for scientists funded by both…...
Ricardo Garcia: The Power of Repurposing
When volasertib was discontinued after an unsatisfactory Phase III clinical trial as an anti-leukemia drug, it did not die a quick death, or die at all. Like Viagra and thalidomide before it, volasertib was “repurposed;” if the original vision for the compound fails, it is simply a matter of finding…...
NFCR Funded Translational Cancer Research Project Receives Virginia Catalyst Grant
FOR IMMEDIATE RELEASE: December 23, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance…...